epigallocatechin gallate has been researched along with Neuroblastoma in 27 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 10 (37.04) | 29.6817 |
2010's | 13 (48.15) | 24.3611 |
2020's | 4 (14.81) | 2.80 |
Authors | Studies |
---|---|
Fan, H; Hu, CL; Hu, JF; Ma, GL; Pan, LL; Wang, W; Xiong, J; Yang, GX; Zhang, HY; Zhao, QH | 1 |
Ayyalasomayajula, N; Bandaru, LJM; Challa, S; Chetty, CS; Dixit, PK | 1 |
Ikebukuro, K; Kaku, T; Tsukakoshi, K | 1 |
Cosar, MY; Erdogan, MA; Yilmaz, O | 1 |
Liang, Z; Wan, X; Wang, W | 1 |
Hong, H; Li, Y; Su, B | 1 |
Hara, A; Iguchi, K; Minami, A; Nakagawa, A; Nakamura, Y; Nanjo, F; Pervin, M; Takagaki, A; Unno, K | 1 |
Farabegoli, F; Govoni, M; Papi, A; Spisni, E | 1 |
Beesley, S; Bienkiewicz, EA; Olcese, J; Saunders, C | 1 |
Chan, P; Wang, L; Xu, S; Xu, X | 1 |
Tai, KK; Truong, DD | 1 |
Huang, W; Li, C; Li, J; Niu, H; Xue, X | 1 |
Banik, NL; Karmakar, S; Mohan, N; Ray, SK | 1 |
Hartomo, TB; Hasegawa, D; Hayakawa, A; Iijima, K; Kawasaki, K; Kosaka, Y; Kubokawa, I; Lee, MJ; Matsuo, M; Mori, T; Morikawa, S; Nishimura, N; Nishio, H; Pham, TV; Takeda, H; Takeshima, Y; Yamamoto, N; Yamamoto, T; Yanai, T | 1 |
Bieschke, J; Fecht, HJ; Friedrich, RP; Hunstein, W; Mereles, D; Sommer, AP; Wanker, EE; Zhu, D | 1 |
Banik, NL; Chakrabarti, M; Khandkar, M; Ray, SK | 1 |
Banik, NL; Hossain, MM; Ray, SK | 1 |
Ho, A; Peritore, CS; Schaus, SE; Yamamoto, BK | 1 |
Mandel, S; Weinreb, O; Youdim, MB | 1 |
Choi, BS; Jeong, JH; Kim, HJ; Kim, MK; Lee, TJ; Park, ES | 1 |
Fang, D; Huang, YG; Le, WD; Li, R | 1 |
Amit, T; Avramovich-Tirosh, Y; Mandel, S; Reznichenko, L; Weinreb, O; Youdim, MB; Zheng, H | 1 |
Kalfon, L; Mandel, SA; Youdim, MB | 1 |
Lee, KW; Lee, SJ | 1 |
Chung, WG; Maier, CS; Miranda, CL | 1 |
Avramovich-Tirosh, Y; Fridkin, M; Mandel, S; Mit, T; Reznichenko, L; Weinreb, O; Youdim, MB; Zheng, H | 1 |
Amit, T; Weinreb, O; Youdim, MB | 1 |
27 other study(ies) available for epigallocatechin gallate and Neuroblastoma
Article | Year |
---|---|
Biginkgosides A-I, Unexpected Minor Dimeric Flavonol Diglycosidic Truxinate and Truxillate Esters from Ginkgo biloba Leaves and Their Antineuroinflammatory and Neuroprotective Activities.
Topics: Amyloid beta-Peptides; Cell Survival; Drugs, Chinese Herbal; Esters; Flavonols; Ginkgo biloba; Glycosides; Lipopolysaccharides; Macrophages; Molecular Structure; Neuroblastoma; Neuroprotective Agents; Nitric Oxide; Nuclear Magnetic Resonance, Biomolecular; Peptide Fragments; Plant Extracts; Plant Leaves | 2016 |
Mitochondria-Mediated Moderation of Apoptosis by EGCG in Cytotoxic Neuronal Cells Induced by Lead (Pb) and Amyloid Peptides.
Topics: Antioxidants; Apoptosis; Catechin; Cytochromes c; Humans; Lead; Mitochondria; Neuroblastoma; Oxidants; Oxidative Stress; Peptides | 2022 |
Cytotoxic Aβ Protofilaments Are Generated in the Process of Aβ Fibril Disaggregation.
Topics: Amyloid; Amyloid beta-Peptides; Antioxidants; Catechin; Dopamine; Dopamine Agents; Humans; Neuroblastoma; Tumor Cells, Cultured | 2021 |
Epigallocatechin-3-gallate and resveratrol attenuate hydrogen peroxide induced damage in neuronal cells.
Topics: Apoptosis; Caspase 3; Catechin; Humans; Hydrogen Peroxide; Neuroblastoma; Resveratrol | 2023 |
Epigallocatechin-3-gallate inhibits the growth of three-dimensional in vitro models of neuroblastoma cell SH-SY5Y.
Topics: Anticarcinogenic Agents; Apoptosis; Catechin; Cell Culture Techniques; Cell Proliferation; Coculture Techniques; Human Umbilical Vein Endothelial Cells; Humans; Neuroblastoma; Tumor Cells, Cultured | 2021 |
Identification of Circulating miR-125b as a Potential Biomarker of Alzheimer's Disease in APP/PS1 Transgenic Mouse.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Biomarkers; Catechin; Cell Line, Tumor; Cognition Disorders; Disease Models, Animal; Gene Expression Regulation; Humans; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; MicroRNAs; Mutation; Neuroblastoma; Presenilin-1; Protease Inhibitors; RNA, Messenger | 2017 |
Blood-Brain Barrier Permeability of Green Tea Catechin Metabolites and their Neuritogenic Activity in Human Neuroblastoma SH-SY5Y Cells.
Topics: Blood-Brain Barrier; Catechin; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Humans; Lactones; Neurites; Neuroblastoma; Pyrogallol; Tea | 2017 |
Epigallocatechin-3-gallate and 6-OH-11-O-Hydroxyphenanthrene Limit BE(2)-C Neuroblastoma Cell Growth and Neurosphere Formation In Vitro.
Topics: Apoptosis; Catechin; Cell Line, Tumor; Cell Survival; Drug Synergism; Gene Expression Regulation, Neoplastic; Genes, myc; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplastic Stem Cells; Neuroblastoma; Phenanthrenes; Tea | 2018 |
Combinatorial Treatment Effects in a Cell Culture Model of Alzheimer's Disease.
Topics: Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Antipsychotic Agents; Catechin; Cell Line, Tumor; Cytokines; Drug Combinations; Gene Expression Regulation, Neoplastic; Humans; Melatonin; Mice; Mutation; Neuroblastoma; Peptide Fragments; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Resveratrol; Stilbenes; Transfection | 2017 |
(-)-Epigallocatechin-3-Gallate protects SH-SY5Y cells against 6-OHDA-induced cell death through STAT3 activation.
Topics: Adrenergic Agents; Analysis of Variance; Catechin; Cell Death; Cell Differentiation; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Interactions; Humans; Neuroblastoma; Neuroprotective Agents; Oxidopamine; STAT3 Transcription Factor; Tetrazolium Salts; Thiazoles; Thymidine; Time Factors; Tritium; Tyrosine | 2009 |
(-)-Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, reduces dichlorodiphenyl-trichloroethane (DDT)-induced cell death in dopaminergic SHSY-5Y cells.
Topics: Catechin; Cell Death; Cell Line, Tumor; Cell Survival; DDT; Dopamine; Humans; Neuroblastoma; Neuroprotective Agents; Pesticides | 2010 |
Robinetinidol-(4beta-->8)-epigallocatechin 3-O-gallate, a galloyl dimer prorobinetinidin from Acacia mearnsii De Wild, effectively protects human neuroblastoma SH-SY5Y cells against acrolein-induced oxidative damage.
Topics: Acacia; Acrolein; Caspase 3; Catechin; Cell Line, Tumor; Cell Survival; Dimerization; Flavonoids; Humans; Lipid Peroxidation; NADPH Oxidases; Nerve Degeneration; Neuroblastoma; Neurons; Neuroprotective Agents; Oxidative Stress | 2010 |
SU5416 and EGCG work synergistically and inhibit angiogenic and survival factors and induce cell cycle arrest to promote apoptosis in human malignant neuroblastoma SH-SY5Y and SK-N-BE2 cells.
Topics: Angiogenesis Inhibitors; Anticarcinogenic Agents; Apoptosis; Catechin; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Survival; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; E2F1 Transcription Factor; Humans; In Situ Nick-End Labeling; Indoles; Neovascularization, Pathologic; Neuroblastoma; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Pyrroles; Retinoblastoma Protein; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2011 |
Epigallocatechin gallate inhibits sphere formation of neuroblastoma BE(2)-C cells.
Topics: Anticarcinogenic Agents; Apoptosis; Catechin; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Dose-Response Relationship, Drug; Humans; Neuroblastoma; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction | 2012 |
670 nm laser light and EGCG complementarily reduce amyloid-β aggregates in human neuroblastoma cells: basis for treatment of Alzheimer's disease?
Topics: Adenosine Triphosphate; Alzheimer Disease; Amyloid; Antineoplastic Agents; Brain Neoplasms; Catechin; Humans; Low-Level Light Therapy; Microscopy, Fluorescence; Neuroblastoma; Tumor Cells, Cultured; Ultrasonography | 2012 |
Alterations in expression of specific microRNAs by combination of 4-HPR and EGCG inhibited growth of human malignant neuroblastoma cells.
Topics: Antineoplastic Agents; Apoptosis; Catechin; Cell Line, Tumor; Cell Survival; Fenretinide; Humans; MicroRNAs; Neuroblastoma | 2012 |
Survivin knockdown increased anti-cancer effects of (-)-epigallocatechin-3-gallate in human malignant neuroblastoma SK-N-BE2 and SH-SY5Y cells.
Topics: Antineoplastic Agents; Apoptosis; Base Sequence; Caspases; Catechin; Cell Differentiation; Cell Line, Tumor; Cell Movement; Gene Knockdown Techniques; Humans; Inhibitor of Apoptosis Proteins; Neovascularization, Pathologic; Neuroblastoma; RNA, Messenger; RNA, Neoplasm; RNA, Small Interfering; Survivin | 2012 |
Resveratrol attenuates L-DOPA-induced hydrogen peroxide toxicity in neuronal cells.
Topics: Antioxidants; Catechin; Cell Line, Tumor; Cell Survival; Drug Evaluation, Preclinical; Drug Interactions; Fibroblasts; Fluoresceins; Humans; Hydrogen Peroxide; Levodopa; Monoamine Oxidase; Nerve Tissue Proteins; Neuroblastoma; Neurons; Neuroprotective Agents; Oxidative Stress; Quercetin; Resveratrol; Stilbenes; Tyrosine; Tyrosine 3-Monooxygenase | 2012 |
cDNA gene expression profile homology of antioxidants and their antiapoptotic and proapoptotic activities in human neuroblastoma cells.
Topics: Antioxidants; Apomorphine; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspases; Catechin; Cell Survival; Dopamine; Dose-Response Relationship, Drug; Gene Expression Profiling; Gene Expression Regulation; Humans; Melatonin; Neuroblastoma; Oligonucleotide Array Sequence Analysis; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured | 2003 |
Epigallocatechin 3-gallate attenuates neuronal damage induced by 3-hydroxykynurenine.
Topics: Apoptosis; Caspase 3; Caspases; Catechin; Cell Survival; Dose-Response Relationship, Drug; Humans; Kynurenine; Neuroblastoma; Neurons; Neuroprotective Agents; Reactive Oxygen Species; Tumor Cells, Cultured | 2004 |
(-)-Epigallocatechin gallate inhibits lipopolysaccharide-induced microglial activation and protects against inflammation-mediated dopaminergic neuronal injury.
Topics: Analysis of Variance; Animals; Animals, Newborn; Antioxidants; Blotting, Western; Carbocyanines; Catechin; Cell Count; Cells, Cultured; Culture Media, Conditioned; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Enzyme-Linked Immunosorbent Assay; Humans; Inflammation; Lipopolysaccharides; Microglia; Microtubule-Associated Proteins; Neuroblastoma; Neurons; Nitric Oxide; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazolium Salts; Thiazoles; Time Factors; Tumor Necrosis Factor-alpha; Tyrosine 3-Monooxygenase | 2004 |
Reduction of iron-regulated amyloid precursor protein and beta-amyloid peptide by (-)-epigallocatechin-3-gallate in cell cultures: implications for iron chelation in Alzheimer's disease.
Topics: Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Antigens, CD; Blotting, Western; Catechin; Cell Line, Tumor; CHO Cells; Cricetinae; Cricetulus; Deferoxamine; Dose-Response Relationship, Drug; Drug Interactions; Electrophoresis, Gel, Two-Dimensional; Gene Expression; Humans; Immunoprecipitation; Iron; Iron Chelating Agents; Neuroblastoma; Neuroprotective Agents; Receptors, Transferrin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transfection | 2006 |
Green tea polyphenol (-) -epigallocatechin-3-gallate promotes the rapid protein kinase C- and proteasome-mediated degradation of Bad: implications for neuroprotection.
Topics: bcl-Associated Death Protein; Blotting, Western; Catechin; Cell Line, Tumor; Cell Survival; Chymotrypsin; Drug Interactions; Enzyme Inhibitors; Gene Expression Regulation; Humans; Models, Biological; Neuroblastoma; Neuroprotective Agents; Proteasome Endopeptidase Complex; Protein Kinase C; Time Factors; Transfection | 2007 |
Protective effect of (-)-epigallocatechin gallate against advanced glycation endproducts-induced injury in neuronal cells.
Topics: Annexin A5; Antioxidants; Apoptosis; Catalase; Catechin; Cell Line, Tumor; Cell Survival; Glutathione Peroxidase; Glycation End Products, Advanced; Humans; Indicators and Reagents; Lipid Peroxidation; Malondialdehyde; Neuroblastoma; Neurons; Neuroprotective Agents; Oxidative Stress; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Superoxide Dismutase | 2007 |
Epigallocatechin gallate (EGCG) potentiates the cytotoxicity of rotenone in neuroblastoma SH-SY5Y cells.
Topics: Antioxidants; Brain; Catechin; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Synergism; Humans; Insecticides; Neuroblastoma; Neurons; Oxidative Stress; Parkinson Disease; Reactive Oxygen Species; Rotenone; Superoxides | 2007 |
Neurorescue activity, APP regulation and amyloid-beta peptide reduction by novel multi-functional brain permeable iron- chelating- antioxidants, M-30 and green tea polyphenol, EGCG.
Topics: Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Antioxidants; Apoptosis; Catechin; Cell Line, Tumor; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Hydroxyquinolines; Mice; Mice, Inbred C57BL; Models, Biological; Neuroblastoma | 2007 |
The application of proteomics for studying the neurorescue activity of the polyphenol (-)-epigallocatechin-3-gallate.
Topics: Catechin; Cell Culture Techniques; Cell Line, Tumor; Cell Survival; Culture Media, Serum-Free; Dose-Response Relationship, Drug; Flavonoids; Gene Expression; Humans; Neuroblastoma; Phenols; Polyphenols; Proteomics | 2008 |